7INVENSUN is an artificial company offering machine vision and eye-tracking technologies. It completed a series C funding round worth hundreds of millions of CNY in March 2022, led by TH Capital.
Founded in 2009 and headquartered in Beijing, 7INVENSUN (Chinese: 北京七鑫易维信息技术有限公司) is a high-tech company focusing on vision-related technologies. It completed a series C funding round worth hundreds of millions of CNY in March 2022, led by TH Capital, with participation by WELL-LINK, Xiamen Supu capital and Tsinghua Alumni Fund. 7INVENSUN will use the capital for R&D investment activities and expanding the current business scale.
7INVENSUN is China's first eye-tracking solution provider, launching the world's first eye-control smart glasses in 2010. The product line covers XR eye movement, eye movement analysis and communication aids, serving customers in education, scientific research, new energy cars and medical fields.
As a technology-driven technology company, more than 70% of 7INVENSUN employees are in the R&D department. This, in return, explains why 7INVENSUN possesses more than 500 global patents. 7INVENSUN promotes the coordinated implementation of the Comprehensive Strategy, reaching on wearable devices (VR/AR/MR), human-computer interaction, eye tracking algorithm, intelligent driving technology and image processing technologies. The patents, combined with the continuous developments of 7INVENSUN, help itself establish the industry's dominance.
7INVENSUN has won several national and provincial honors for its representative products, harvesting millions of CNY from the government. Additionally, 7INVENSUN successfully participated in several critical national projects and was appraised by the officials.
7INVENSUN 's competitors include SensoMotoric Instruments, EyeLink, Smart Eye, LC technologies, Gazepoint, The Eye Tribe, Pupil Labs, Mirametrix, Ergoneers and EyeTech.